BABA vs PSNYW

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

The deterministic health profile is critically weak, highlighted by a Piotroski F-Score of 3/9 and a complete absence of a Graham Number due to negative earnings and equity. The company is facing a severe liquidity crisis with a current ratio of 0.43 and a quick ratio of 0.21, indicating an inability to meet short-term obligations. Most alarmingly, the gross margin is -32.68%, meaning the company loses money on every vehicle produced before operating expenses. While revenue growth remains positive at 26.10%, the negative Price/Book ratio (-0.06) and bearish technical trend (0/100) suggest a high risk of insolvency or massive dilution.